Ross Abrams to Etoposide
This is a "connection" page, showing publications Ross Abrams has written about Etoposide.
Connection Strength
0.067
-
Split-course chemoradiotherapy for locally advanced non-small cell lung cancer: a single-institution experience of 144 patients. J Thorac Oncol. 2011 Jun; 6(6):1079-86.
Score: 0.025
-
Phase II study of combination chemotherapy with etoposide and amsacrine in relapsed adult leukemia. Cancer Treat Rep. 1986 Apr; 70(4):535.
Score: 0.018
-
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. J Clin Oncol. 2005 Aug 01; 23(22):4991-8.
Score: 0.017
-
Yttrium 90-labeled antiferritin followed by high-dose chemotherapy and autologous bone marrow transplantation for poor-prognosis Hodgkin's disease. J Clin Oncol. 1993 Apr; 11(4):698-703.
Score: 0.007